Related Experiment Videos
[Management of amyotrophic lateral sclerosis]
P Bouche1, P Castaigne, V Meininger
1Service d'explorations fonctionnelles, Hôpital de la Salpêtrière, Paris.
Revue Neurologique
|January 1, 1989
Summary
Amyotrophic Lateral Sclerosis (ALS) lacks a specific cure, but symptomatic treatments are improving patient management. Focus is shifting towards managing respiratory insufficiency and utilizing supportive therapies for better outcomes.
Area of Science:
- Neurology
- Clinical Medicine
Context:
- Amyotrophic Lateral Sclerosis (ALS) presents significant management challenges due to the absence of a specific cure.
- Patient advocacy groups play a crucial role in driving research for causes and treatments.
- Recent advancements offer symptomatic therapeutic resources to improve patient care.
Purpose:
- To review current symptomatic therapeutic resources for Amyotrophic Lateral Sclerosis (ALS).
- To highlight key management strategies for ALS, including nutritional and respiratory support.
- To emphasize the multidisciplinary approach required for effective ALS patient care.
Summary:
- Current ALS management focuses on symptomatic relief, including gastric tubes for nutritional support and addressing early respiratory insufficiency.
- Therapeutic options encompass medications for spasticity, cramps, and drooling, alongside crucial physiotherapy and speech therapy.
- Home-based respiratory assistance devices are becoming increasingly relevant in managing ALS progression.
Impact:
- Improved symptomatic management can enhance the quality of life for patients with Amyotrophic Lateral Sclerosis (ALS).
- The integration of respiratory support and multidisciplinary care represents a significant step forward in ALS patient management.
- Enhanced patient care strategies underscore the importance of a collaborative approach involving healthcare professionals and families.